Format

Send to

Choose Destination
Dialogues Clin Neurosci. 2017 Jun;19(2):93-107.

Treatment of anxiety disorders.

Author information

1
Department of Psychiatry and Psychotherapy, University Medical Center, Gottingen, Germany.

Abstract

in English, French, Spanish

Anxiety disorders (generalized anxiety disorder, panic disorder/agoraphobia, social anxiety disorder, and others) are the most prevalent psychiatric disorders, and are associated with a high burden of illness. Anxiety disorders are often underrecognized and undertreated in primary care. Treatment is indicated when a patient shows marked distress or suffers from complications resulting from the disorder. The treatment recommendations given in this article are based on guidelines, meta-analyses, and systematic reviews of randomized controlled studies. Anxiety disorders should be treated with psychological therapy, pharmacotherapy, or a combination of both. Cognitive behavioral therapy can be regarded as the psychotherapy with the highest level of evidence. First-line drugs are the selective serotonin reuptake inhibitors and serotonin-norepinephrine reuptake inhibitors. Benzodiazepines are not recommended for routine use. Other treatment options include pregabalin, tricyclic antidepressants, buspirone, moclobemide, and others. After remission, medications should be continued for 6 to 12 months. When developing a treatment plan, efficacy, adverse effects, interactions, costs, and the preference of the patient should be considered.

KEYWORDS:

drug treatment; generalized anxiety disorder; panic disorder; psychotherapy; social anxiety disorder; treatment

PMID:
28867934
PMCID:
PMC5573566
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Dialogues in Clinical Neuroscience Icon for PubMed Central
Loading ...
Support Center